Original Article

The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study


Background: Leishmaniasis is currently considered a re-emerging or emerging infection based on the geographic region. The outcome of leishmaniasis vastly depends on Leishmania-host interaction. This preliminary study aimed to show the association of human leukocyte antigen (HLA) class I and II genes with healed and non-healed cutaneous leishmaniasis (CL), and symptomatic and asymptomatic visceral leishmaniasis (VL) compared with control groups in Iran.

Methods: Ninety-five people, including 31 patients versus 64 individuals in the control group, were enrolled. Among them, 20 patients had confirmed CL based on amastigote observation, 10 had improved CL and 10 non-healed CL. Eleven patients were suffering from confirmed VL based on direct agglutination test (Five asymptomatic and six symptomatic VL cases). Besides, they were residents in an endemic area of VL in the northwest of Iran. To select a control group, it was ensured that they had no history of leishmaniasis. Peripheral blood samples were collected from each patient. After DNA extraction, HLA typing was conducted using polymerase chain reaction - sequence-specific priming (PCR-SSP). Subsequently, data were statistically analyzed by SPSS.  

Results: There was a statistical relationship between the presence of HLA-A26 and CL, healed CL and the existence of the B38 allele, C1 allele and symptomatic VL, as well as B1.4 allele and asymptomatic VL (P˂0.05).

Conclusion: This primary finding indicates that several HLA genes have a potential role in the susceptibility of Iranian people to CL and VL.

1. Brazil RP, Rodrigues AAF, Andrade Fil-ho JD. Sand fly vectors of Leishmania in the Americas-a mini review. Entomol Ornithol Herpetol. 2015; 4 (2):1.
2. Samaranayake N, Fernando SD, Neth-thikumara NF, Rodrigo C, Karunaweera ND, Dissanayake VH. Association of HLA class I and II genes with cutaneous leishmaniasis: a case control study from Sri Lanka and a systematic review. BMC Infect Dis. 2016; 16:292.
3. Leishmaniasis: World Health Organiza-tion; 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/leishmaniasis.
4. Sakthianandeswaren A, Foote SJ, Handman E. The role of host genetics in leishmaniasis. Trends Parasitol. 2009; 25 (8):383-91.
5. Verma N, Bimal S, Das VNR, et al. Clinicopathological and immunological changes in Indian post kala-azar dermal leishmaniasis (PKDL) cases in relation to treatment: A retrospective study. Bi-omed Res Int. 2015; 2015:745062.
6. Mansueto P, Seidita A, Vitale G, Cascio A. Leishmaniasis in travelers: a literature review. Travel Med Infect Dis. 2014; 12(6 Pt A):563-81.
7. Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Mi-crobiol Rev. 2009; 22(2):370-85.
8. Lipoldová M, Demant P. Genetic sus-ceptibility to infectious disease: lessons from mouse models of leishmaniasis. Nat Rev Genet. 2006; 7(4):294-305.
9. Nateghi Rostami M, Keshavarz H, Eda-lat R, et al. CD8+ T cells as a source of IFN-γ production in human cutaneous leishmaniasis. PLoS Negl Trop Dis. 2010; 4(10):e845.
10. da Silva Santos C, Brodskyn CI. The role of CD4 and CD8 T cells in human cutaneous leishmaniasis. Front Public Health. 2014; 2:165.
11. Mohebali M, Keshavarz H, Shirmo-hammad S, et al. The diagnostic accura-cy of direct agglutination test for sero-diagnosis of human visceral leishmani-asis: a systematic review with meta-analysis. BMC Infect Dis. 2020; 20(1):946.
12. Mohebali M. Visceral leishmaniasis in Iran: review of the epidemiological and clinical features. Iran J Parasitol. 2013; 8 (3):348-358.
13. Mohebali M, Edrissian GH, Shirzadi MR, et al. An observational study on the current distribution of visceral leish-maniasis in different geographical zones of Iran and implication to health policy. Travel Med Infect Dis. 2011; 9(2):67-74.
14. Singh AK, Das VNR, Ajay A, et al. Iden-tification of clinical immunological de-terminants in asymptomatic VL and post kala-azar dermal leishmaniasis pa-tients. Iran J Parasitol. 2018; 13 (4):541-548.
15. Shahsavar F, Varzi A-M, Ahmadi SAY. A genomic study on distribution of hu-man leukocyte antigen (HLA)-A and HLA-B alleles in Lak population of Iran. Genom Data. 2017; 11:3-6.
16. Mohammadpour I, Hatam GR, Handja-ni F, et al. Leishmania cytochrome b gene sequence polymorphisms in southern Iran: relationships with differ-ent cutaneous clinical manifestations. BMC Infect Dis. 2019; 19 (1):1-13.
17. Esmaeili A, Rabe SZT, Mahmoudi M, Rastin M. Frequencies of HLA-A, B and DRB1 alleles in a large normal popula-tion living in the city of Mashhad, Northeastern Iran. Iran J Basic Med Sci. 2017; 20 (8):940-3.
18. Barbier D, Demenais F, Lefait J, et al. Susceptibility to human cutaneous leishmaniasis and HLA, Gm, Km mark-ers. Tissue Antigens. 1987; 30(2):63-7.
19. Lara M, Layrisse Z, Scorza J, et al. Im-munogenetics of human American cu-taneous leishmaniasis: study of HLA haplotypes in 24 families from Vene-zuela. Hum Immunol. 1991; 30(2):129-35.
20. Petzl-Erler M, Belich M, Queiroz-Telles F. Association of mucosal leishmaniasis with HLA. Hum Immunol. 1991; 32(4):254-60.
21. Castellucci LC, Almeida LFd, Jamieson SE, Fakiola M, Carvalho EMd, Blackwell JM. Host genetic factors in American cutaneous leishmaniasis: a critical ap-praisal of studies conducted in an en-demic area of Brazil. Mem Inst Oswal-do Cruz. 2014; 109(3):279-88.
22. Dikhit M, Amit A, Singh A, et al. Vac-cine potential of HLA‐A2 epitopes from Leishmania Cysteine Protease Type III (CPC). Parasite Immunol. 2017; 39(9):e12451.
23. Castellucci L, Jamieson S, Miller E, et al. FLI1 polymorphism affects susceptibil-ity to cutaneous leishmaniasis in Brazil. Genes Immun. 2011; 12(7):589-94.
24. Sakthianandeswaren A, Curtis JM, Elso C, et al. Fine mapping of Leishmania ma-jor susceptibility Locus lmr2 and evi-dence of a role for Fli1 in disease and wound healed. Infect Immun. 2010; 78(6):2734-44.
25. Castellucci L, Menezes E, Oliveira J, et al. IL6− 174 G/C promoter polymor-phism influences susceptibility to mu-cosal but not localized cutaneous leishmaniasis in Brazil. J Infect Dis. 2006; 194(4):519-27.
26. Salhi A, Rodrigues V, Santoro F, et al. Immunological and genetic evidence for a crucial role of IL-10 in cutaneous lesions in humans infected with Leish-mania braziliensis. J Immunol. 2008; 180(9):6139-48.
27. Meddeb-Garnaoui A, Gritli S, Garbouj S, et al. Association analysis of HLA-class II and class III gene polymor-phisms in the susceptibility to Mediter-ranean visceral leishmaniasis. Hum Immunol. 2001; 62(5):509-17.
28. Faghiri Z, Tabei S, Taheri F. Study of the association of HLA class I antigens with kala-azar. Hum Hered. 1995; 45(5):258-61.
29. Fakiola M, Strange A, Cordell HJ, et al. Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are as-sociated with susceptibility to visceral leishmaniasis. Nat Genet. 2013; 45(2):208-13.
IssueVol 18 No 2 (2023) QRcode
SectionOriginal Article(s)
DOI https://doi.org/10.18502/ijpa.v18i2.13181
Leishmaniasis Immunology HLA Genes Iran

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Eimanzadeh M, Mohebali M, Zarrabi M, Rahimi Foroushani A, Kazemi M, Hajjaran H, Zarei Z, Kakooei Z, akhoundi B. The Association of Human Leucocyte Antigen (HLA) Class I and II Genes with Cutaneous and Visceral Leishmaniasis in Iranian Patients: A Preliminary Case-Control Study. Iran J Parasitol. 2023;18(2):155-164.